CEO James Clemmer was paid $6,060,145 in fiscal year 2026, ↑ up 10.3% from fiscal year 2025, the 38th percentile of its disclosed peer group (SEC filing 0001140361-26-039022 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$6,060,145 ↑ James Clemmer total, FY2026 | 38th CEO pay percentile vs peers | 45:1 CEO-to-median pay ratio | 93.18% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
ANGO's next annual pay disclosure, estimated October 8, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| James Clemmer | $828,171 | $0 | $3,689,866 | $0 | $1,502,491 | $0 | $39,617 | $6,060,145 |
| President, CEO | ||||||||
| Stephen Trowbridge | 471,305 | 0 | 1,556,376 | 0 | 598,538 | 0 | 35,751 | 2,661,970 |
| EVP, CFO | ||||||||
| Laura Piccinini | 470,563 | 0 | 580,047 | 0 | 500,422 | 0 | 57,655 | 1,608,687 |
| SVP & GM, Cardiovascular and International | ||||||||
| Lawrence Weiss | 439,427 | 0 | 552,801 | 0 | 478,332 | 0 | 23,769 | 1,494,329 |
| SVP, Chief Legal Officer & Corporate Secretary | ||||||||
| Warren Nighan | 416,304 | 0 | 525,054 | 0 | 454,313 | 0 | 35,811 | 1,431,482 |
| SVP & GM, Global Supply Chain, Quality and Regulatory Affairs | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2026 total | FY2025 total | FY2024 total | Δ FY2025→2026 |
|---|---|---|---|---|
| James Clemmer | $6,060,145 | $5,494,285 | $5,005,971 | ↑ +565,860 |
| Stephen Trowbridge | 2,661,970 | 2,161,797 | 1,822,254 | ↑ +500,173 |
| Laura Piccinini | 1,608,687 | 1,369,426 | 1,229,380 | ↑ +239,261 |
| Lawrence Weiss | 1,494,329 | 1,170,067 | — | ↑ +324,262 |
| Warren Nighan | 1,431,482 | 1,165,146 | 995,082 | ↑ +266,336 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read ANGIODYNAMICS INC's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper ANGO reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
Get the ANGIODYNAMICS INC Peer Teardown Report
$6,060,145 James Clemmer total, FY2026
$199
The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.
Data as of October 16, 2026 · Source: 0001140361-26-039022 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
Reports for ANGO
Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:
Order ANGO
Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.
How we handle your data → Privacy
The list of companies that name ANGO as a peer is temporarily unavailable — recheck shortly.
Get the ANGIODYNAMICS INC Executive Compensation Report
$1,500
One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.
| Executive | Role | FY2026 total |
|---|---|---|
| James Clemmer | CEO | $6,060,145 |
| Laura Piccinini | SVP | $1,608,687 |
| Lawrence Weiss | General Counsel | $1,494,329 |
| Stephen Trowbridge | CFO | $2,661,970 |
| Warren Nighan | SVP | $1,431,482 |
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2026 total |
|---|---|---|
| Eileen O. Auen | Independent Director | $242,005 |
| Howard W. Donnelly | Chair of the Board | $272,005 |
| Jan Stern Reed | Independent Director | $244,505 |
| Karen A. Licitra | Independent Director | $234,505 |
| Lorinda A. Burgess | Independent Director | $234,505 |
| Michael E. Tarnoff | Independent Director | $232,005 |
| Wesley E. Johnson, Jr | Independent Director | — |
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| James Clemmer | PSU | 2025-07-16 | 33,000 | 206,253 | — | 495,007 | $1,916,090 |
| James Clemmer | RSU | 2025-07-16 | — | — | 206,253 | — | 1,773,776 |
| Warren Nighan | PSU | 2025-07-16 | 4,696 | 29,349 | — | 70,438 | 272,652 |
| Laura Piccinini | PSU | 2025-07-16 | 5,188 | 32,423 | — | 77,815 | 301,210 |
| Lawrence Weiss | RSU | 2025-07-16 | — | — | 30,900 | — | 265,740 |
| Lawrence Weiss | PSU | 2025-07-16 | 4,944 | 30,900 | — | 74,160 | 287,061 |
| Warren Nighan | RSU | 2025-07-16 | — | — | 29,349 | — | 252,401 |
| Laura Piccinini | RSU | 2025-07-16 | — | — | 32,423 | — | 278,838 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| James Clemmer | $1,773,776 | $1,916,090 | $0 | 51.9% |
| Warren Nighan | 252,401 | 272,652 | 0 | 51.9% |
| Laura Piccinini | 278,838 | 301,210 | 0 | 51.9% |
| Lawrence Weiss | 265,740 | 287,061 | 0 | 51.9% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| James Clemmer | PSU | 7,633 | — | $87,627 |
| James Clemmer | PSU | 211,622 | — | 2,429,421 |
| James Clemmer | PSU | 206,253 | — | 2,367,784 |
| James Clemmer | RSU | 206,253 | — | 2,367,784 |
| James Clemmer | PSU | 184,361 | — | 2,116,464 |
| Laura Piccinini | RSU | 11,411 | — | 130,998 |
| Stephen Trowbridge | PSU | 86,997 | — | 998,726 |
| Stephen Trowbridge | RSU | 86,997 | — | 998,726 |
| James Clemmer | RSU | 79,359 | — | 911,041 |
| Stephen Trowbridge | PSU | 77,905 | — | 894,349 |
| Stephen Trowbridge | PSU | 57,381 | — | 658,734 |
| James Clemmer | RSU | 46,091 | — | 529,125 |
| Lawrence Weiss | RSU | 39,523 | — | 453,724 |
| Laura Piccinini | PSU | 32,423 | — | 372,216 |
| Laura Piccinini | RSU | 32,423 | — | 372,216 |
| Lawrence Weiss | PSU | 30,900 | — | 354,732 |
| Lawrence Weiss | RSU | 30,900 | — | 354,732 |
| Laura Piccinini | PSU | 30,428 | — | 349,313 |
| Warren Nighan | PSU | 29,349 | — | 336,927 |
| Warren Nighan | RSU | 29,349 | — | 336,927 |
| Stephen Trowbridge | RSU | 29,215 | — | 335,388 |
| Laura Piccinini | PSU | 28,336 | — | 325,297 |
| Warren Nighan | PSU | 23,952 | — | 274,969 |
| Warren Nighan | PSU | 20,052 | — | 230,197 |
| Stephen Trowbridge | RSU | 14,346 | — | 164,692 |
| Warren Nighan | RSU | 8,982 | — | 103,113 |
| James Clemmer | RSU | 8,274 | — | 94,986 |
| Laura Piccinini | RSU | 7,084 | — | 81,324 |
| Laura Piccinini | RSU | 5,068 | — | 58,181 |
| Warren Nighan | RSU | 5,068 | — | 58,181 |
| Warren Nighan | RSU | 5,014 | — | 57,561 |
| James Clemmer | RSU | 2,863 | — | 32,867 |
| Stephen Trowbridge | RSU | 1,991 | — | 22,857 |
| Laura Piccinini | RSU | 1,101 | — | 12,639 |
| Warren Nighan | RSU | 857 | — | 9,838 |
| James Clemmer | Option | 19,382 | 21.53 | — |
| Stephen Trowbridge | Option | 57,343 | 7.4 | — |
| James Clemmer | Option | 95,388 | 8.92 | — |
| James Clemmer | Option | 155,769 | 7.4 | — |
| James Clemmer | Option | 5,599 | 7.18 | — |
| Stephen Trowbridge | Option | 4,662 | 21.53 | — |
| Stephen Trowbridge | Option | 29,688 | 8.92 | — |
| Lawrence Weiss | Option | 77,737 | 7.14 | — |
| Laura Piccinini | Option | 2,578 | 21.53 | — |
| Laura Piccinini | Option | 14,660 | 8.92 | — |
| Laura Piccinini | Option | 22,397 | 7.4 | — |
| Warren Nighan | Option | 2,006 | 21.53 | — |
| Warren Nighan | Option | 10,374 | 8.92 | — |
| Warren Nighan | Option | 17,630 | 7.4 | — |
AngioDynamics generally sets executive compensation targets for cash and equity-based compensation within a competitive range of the 50th percentile of companies in a pre-determined comparable group through a combination of fixed and variable compensation.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Meridian Compensation Partners, LLC |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-11-10 | 28,357,782 | 2,057,982 | 18,842 | 93.18% | Passed |
| 2024 | 2024-11-12 | 26,004,908 | 1,248,479 | 1,035,578 | 91.93% | Passed |
| 2023 | 2023-11-14 | 24,393,365 | 2,193,446 | 6,231 | 91.73% | Passed |
| 2022 | 2022-11-03 | 33,348,202 | 848,967 | 3,034 | 97.52% | Passed |
| 2021 | 2021-11-03 | 32,326,421 | 998,582 | 6,718 | 97% | Passed |
| 2020 | 2020-10-13 | 30,783,204 | 983,044 | 7,449 | 96.88% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2025 | 2025-11-10 | 93.18%a |
| 2024 | 2024-11-12 | 91.93%b |
| 2023 | 2023-11-14 | 91.73%c |
a. Approved under the standard stated in the filing — “broker non-votes are not applicable to this proposal Proposal 3 Approval of the Compensation of our named executive officers on an advisory basis FOR Page 49 No No Majority of the shares represented in person or by proxy and entitled to vote Abstentions will have the effect of a negative vote;”.
b. Approved under the standard stated in the filing — “broker non-votes are not applicable to this proposal Proposal 3 Approval of the Compensation of our named executive officers on an advisory basis FOR Page 50 No No Majority of the shares represented in person or by proxy and entitled to vote Abstentions will have the effect of a negative vote;”.
c. Approved under the standard stated in the filing — “broker non-votes are not applicable to this proposal Proposal 3 Approval of the Compensation of our named executive officers on an advisory basis FOR Page 51 No No Majority of the shares represented in person or by proxy and entitled to vote Abstentions will have the effect of a negative vote;”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 45 : 1 |
|---|---|
| CEO total compensation | — |
| Median employee compensation | $135,741 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Howard W. DonnellyIndependent · Board Chair · Board of Directors (Chair) · Not standing for re-election | $120,000 | $152,005 | — | — | — | $272,005 |
| Wesley E. Johnson JrIndependent · Audit Committee (Chair) · Nominating, Compliance and Corporate Governance Committee | 97,500 | 152,005 | — | — | — | 249,505 |
| Jan Stern ReedIndependent | 92,500 | 152,005 | — | — | — | 244,505 |
| Eileen O. AuenIndependent | 90,000 | 152,005 | — | — | — | 242,005 |
| Lorinda A. BurgessIndependent | 82,500 | 152,005 | — | — | — | 234,505 |
| Karen A. LicitraIndependent | 82,500 | 152,005 | — | — | — | 234,505 |
| Michael E. TarnoffIndependent | 80,000 | 152,005 | — | — | — | 232,005 |
| James C. ClemmerEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $65,000 |
|---|---|
| Annual equity retainer | $152,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 17,500 / 17,500 |
| Stock ownership guideline | $3 |
| Component | FY2026 |
|---|---|
| Cash retainers and fees | $645,000 |
| Equity awards (grant-date value) | $1,064,035 |
| All other compensation | $0 |
| Total cost of the board | $1,709,035 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies ANGIODYNAMICS INC names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including ANGIODYNAMICS INC.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Glaukos Corporation | 2025 | Thomas Burns | $850,000 | $7,649,947 | $3,527,497 | $0 | $12,034,087 |
| 2 | Nevro Corp. | 2023 | Kevin Thornal | 515,625 | 10,080,173 | 0 | 402,750 | 11,453,548 |
| 3 | Alphatec Holdings, Inc. | 2025 | Patrick Miles | 762,000 | 8,859,650 | 0 | 600,000 | 10,260,507 |
| 4 | AtriCure, Inc. | 2025 | Michael Carrel | 828,439 | 7,203,478 | 0 | 1,171,703 | 9,217,620 |
| 5 | AxoGen, Inc. | 2025 | Michael Dale | 775,865 | 7,342,895 | 0 | 906,133 | 9,047,454 |
| 6 | STAAR Surgical Company | 2025 | Stephen Farrell | 580,000 | 6,836,000 | 0 | 0 | 7,522,385 |
| 7 | SI-Bone, Inc. | 2025 | Laura Francis | 685,000 | 6,038,710 | 0 | 729,525 | 7,453,235 |
| 8 | Orthofix Medical Inc. | 2025 | Massimo Calafiore | 848,322 | 4,499,988 | 1,500,009 | 445,579 | 7,310,039 |
| 9 | Cutera, Inc. | 2023 | Taylor Harris | 271,023 | 2,747,682 | 4,250,008 | 0 | 7,279,813 |
| 10 | Artivion, Inc. | 2025 | J. Patrick Mackin | 835,145 | 5,006,990 | 0 | 991,368 | 6,883,108 |
| 11 | ANGIODYNAMICS INC | 2026 | James Clemmer | 828,171 | 3,689,866 | 0 | 1,502,491 | 6,060,145 |
| 12 | Treace Medical Concepts, Inc. | 2025 | John Treace | 755,353 | 4,635,000 | 0 | 0 | 5,405,190 |
| 13 | Accuray Incorporated | 2026 | Steve La Neve | 525,000 | 4,263,749 | 0 | 0 | 5,114,466 |
| 14 | Inari Medical, Inc. | 2023 | Andrew Hykes | 700,000 | 2,606,744 | 937,488 | 826,000 | 5,083,365 |
| 15 | LeMaitre Vascular, Inc. | 2025 | George LeMaitre | 806,347 | 1,050,000 | 1,050,000 | 680,015 | 3,780,990 |
| 16 | Orthopediatrics Corp. | 2025 | David Bailey | 550,000 | 2,445,200 | 0 | 322,281 | 3,331,481 |
| 17 | Zynex, Inc. | 2024 | Thomas Sandgaard | 700,000 | 112,458 | 0 | 170,625 | 991,810 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| ANGIODYNAMICS INC | 180% | PSU 50 · RSU 50 | No | Meridian Compensation Partners, LLC |
| Accuray Incorporated | 0% | PSU 50 · RSU 50 | No | Exequity LLP |
| Alphatec Holdings, Inc. | 157% | PSU 50 · RSU 50 | No | Compensia |
| Artivion, Inc. | 118.7% | PSU 50 · RSU 50 | No | Willis Towers Watson |
| AtriCure, Inc. | 141% | PSU 70 · RSU 30 | No | Korn Ferry |
| AxoGen, Inc. | 116.79% | PSU 50 · RSU 50 | No | Aon |
| Cutera, Inc. | not disclosed | not disclosed | No | Compensia |
| Glaukos Corporation | 177.5% | RSU 50 · PRSU 50 | No | Frederic W. Cook & Co., Inc. |
| Inari Medical, Inc. | 118% | RSU 75 · Option 25 | not disclosed | FW Cook |
| LeMaitre Vascular, Inc. | not disclosed | Option 50 · RSU 25 · PSU 25 | No | not disclosed |
| Nevro Corp. | 53.7% | not disclosed | No | Aon |
| Orthofix Medical Inc. | 47.7% | PSU 50 · Option 25 · RSU 25 | No | Meridian |
| Orthopediatrics Corp. | 78.2% | RSU 100 | not disclosed | NFP Compensation Consulting |
| SI-Bone, Inc. | 106.5% | RSU 50 · PSU 50 | Yes — Relative TSR | Compensia, Inc. |
| STAAR Surgical Company | 135% | RSU 50 · PSU 50 | No | Semler Brossy |
| Treace Medical Concepts, Inc. | not disclosed | RSU 50 · PSU 50 | No | Compensia, Inc. |
| Zynex, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, James Clemmer | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Summary Compensation Table for Fiscal Year 2026” · page 34. As printed: 6,060,145. Filing ↗machine: r2 · c27 · span 739870–739879 |
| 2 | Section 01, Stephen Trowbridge | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Summary Compensation Table for Fiscal Year 2026” · page 34. As printed: 2,661,970. Filing ↗machine: r5 · c27 · span 754792–754801 |
| 3 | Section 01, Laura Piccinini | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Summary Compensation Table for Fiscal Year 2026” · page 34. As printed: 1,608,687. Filing ↗machine: r10 · c27 · span 779368–779377 |
| 4 | Section 01, Lawrence Weiss | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Summary Compensation Table for Fiscal Year 2026” · page 34. As printed: 1,494,329. Filing ↗machine: r8 · c27 · span 769288–769297 |
| 5 | Section 01, Warren Nighan | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Summary Compensation Table for Fiscal Year 2026” · page 34. As printed: 1,431,482. Filing ↗machine: r13 · c27 · span 793916–793925 |
| 6 | Section 03, James Clemmer PSU | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Grants of Plan-Based Awards for Fiscal Year 2026” · grants of plan-based awards table. Filing ↗ |
| 7 | Section 03, James Clemmer RSU | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Grants of Plan-Based Awards for Fiscal Year 2026” · grants of plan-based awards table. Filing ↗ |
| 8 | Section 03, Warren Nighan PSU | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Grants of Plan-Based Awards for Fiscal Year 2026” · grants of plan-based awards table. Filing ↗ |
| 9 | Section 03, Laura Piccinini PSU | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Grants of Plan-Based Awards for Fiscal Year 2026” · grants of plan-based awards table. Filing ↗machine: span 826272–826279 |
| 10 | Section 03, Lawrence Weiss RSU | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Grants of Plan-Based Awards for Fiscal Year 2026” · grants of plan-based awards table. Filing ↗machine: span 647148–647155 |
| 11 | Section 03, Lawrence Weiss PSU | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Grants of Plan-Based Awards for Fiscal Year 2026” · grants of plan-based awards table. Filing ↗ |
| 12 | Section 03, Warren Nighan RSU | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Grants of Plan-Based Awards for Fiscal Year 2026” · grants of plan-based awards table. Filing ↗machine: span 649950–649957 |
| 13 | Section 03, Laura Piccinini RSU | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Grants of Plan-Based Awards for Fiscal Year 2026” · grants of plan-based awards table. Filing ↗machine: span 648490–648497 |
| 14 | Section 07, pay ratio | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “CEO Pay Ratio”. As printed: 45 : 1. Filing ↗ |
| 15 | Section 08, Howard W. Donnelly | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Director Compensation”. As printed: 272,005. Filing ↗machine: span 1611512–1611695 |
| 16 | Section 08, Wesley E. Johnson Jr | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Director Compensation”. As printed: 249,505. Filing ↗machine: span 1613288–1613471 |
| 17 | Section 08, Jan Stern Reed | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Director Compensation”. As printed: 244,505. Filing ↗machine: span 1617091–1617274 |
| 18 | Section 08, Eileen O. Auen | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Director Compensation”. As printed: 242,005. Filing ↗machine: span 1615323–1615506 |
| 19 | Section 08, Lorinda A. Burgess | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Director Compensation”. As printed: 234,505. Filing ↗machine: span 1622840–1623022 |
| 20 | Section 08, Karen A. Licitra | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Director Compensation”. As printed: 234,505. Filing ↗machine: span 1619128–1619311 |
| 21 | Section 08, Michael E. Tarnoff | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Director Compensation”. As printed: 232,005. Filing ↗machine: span 1620897–1621080 |
| 22 | Section 08, James C. Clemmer | DEF 14A | 2026-10-08 | 0001140361-26-039022 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 23 | Section 06, 2025 vote | Form 8-K | 2025-11-12 | 0001140361-25-041542 | Item 5.07 · say-on-pay result. As reported: 93.18% (votes for as printed: 28,357,782). Filing ↗ |
| 24 | Section 06, 2024 vote | Form 8-K | 2024-11-15 | 0001140361-24-047071 | Item 5.07 · say-on-pay result. As reported: 91.93% (votes for as printed: 26,004,908). Filing ↗ |
| 25 | Section 06, 2023 vote | Form 8-K | 2023-11-16 | 0001140361-23-053522 | Item 5.07 · say-on-pay result. As reported: 91.73% (votes for as printed: 24,393,365). Filing ↗ |
| 26 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 27 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 28 | Section 09b board cost (computed) | Computed | — | — | Cash 645,000 + equity 1,064,035 + all other 0 = 1,709,035, summed across the director compensation table rows.machine: formula: Σ = 1,709,035 |
| 29 | Glaukos Corporation, Section 10b CEO total | DEF 14A | 2026-04-16 | 0001193125-26-157829 | CEO total compensation as printed in Glaukos Corporation's own proxy. As printed: 12,034,087. Filing ↗machine: r6 · c38 · span 1876942–1876952 |
| 30 | Nevro Corp., Section 10b CEO total | DEF 14A | 2024-04-12 | 0000950170-24-044100 | CEO total compensation as printed in Nevro Corp.'s own proxy. As printed: 11,453,548. Filing ↗machine: r2 · c16 · span 631983–631993 |
| 31 | Alphatec Holdings, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0001193125-26-191867 | CEO total compensation as printed in Alphatec Holdings, Inc.'s own proxy. As printed: 10,260,507. Filing ↗machine: t26 · r2 · c25 · span 858148–858158 |
| 32 | AtriCure, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001323885-26-000010 | CEO total compensation as printed in AtriCure, Inc.'s own proxy. As printed: 9,217,620. Filing ↗machine: span 743364–743373 |
| 33 | AxoGen, Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0000805928-26-000057 | CEO total compensation as printed in AxoGen, Inc.'s own proxy. As printed: 9,047,454. Filing ↗machine: r2 · c45 · span 557309–557318 |
| 34 | STAAR Surgical Company, Section 10b CEO total | DEF 14A | 2026-05-04 | 0000718937-26-000015 | CEO total compensation as printed in STAAR Surgical Company's own proxy. As printed: 7,522,385. Filing ↗machine: r3 · c16 · span 1045477–1045486 |
| 35 | SI-Bone, Inc., Section 10b CEO total | DEF 14A | 2026-04-21 | 0001459839-26-000049 | CEO total compensation as printed in SI-Bone, Inc.'s own proxy. As printed: 7,453,235. Filing ↗machine: r3 · c18 · span 626969–626978 |
| 36 | Orthofix Medical Inc., Section 10b CEO total | DEF 14A | 2026-04-29 | 0001193125-26-191716 | CEO total compensation as printed in Orthofix Medical Inc.'s own proxy. As printed: 7,310,039. Filing ↗machine: t96 · r4 · c16 · span 1472329–1472338 |
| 37 | Cutera, Inc., Section 10b CEO total | DEF 14A | 2024-06-17 | 0001628280-24-028528 | CEO total compensation as printed in Cutera, Inc.'s own proxy. As printed: 7,279,813. Filing ↗machine: r4 · c46 · span 1221355–1221364 |
| 38 | Artivion, Inc., Section 10b CEO total | DEF 14A | 2026-04-01 | 0001999371-26-007510 | CEO total compensation as printed in Artivion, Inc.'s own proxy. As printed: 6,883,108. Filing ↗machine: r3 · c9 · span 741873–741882 |
| 39 | ANGIODYNAMICS INC (subject), Section 10b CEO total | DEF 14A | 2026-10-08 | 0001140361-26-039022 | CEO total compensation as printed in ANGIODYNAMICS INC's own proxy. As printed: 6,060,145. Filing ↗machine: r2 · c27 · span 739870–739879 |
| 40 | Treace Medical Concepts, Inc., Section 10b CEO total | DEF 14A | 2026-04-06 | 0001630627-26-000005 | CEO total compensation as printed in Treace Medical Concepts, Inc.'s own proxy. As printed: 5,405,190. Filing ↗machine: t81 · r4 · c16 · span 1034150–1034159 |
| 41 | Accuray Incorporated, Section 10b CEO total | DEF 14A | 2026-10-16 | 0001140361-26-039918 | CEO total compensation as printed in Accuray Incorporated's own proxy. As printed: 5,114,466. Filing ↗machine: r2 · c24 · span 597587–597596 |
| 42 | Inari Medical, Inc., Section 10b CEO total | DEF 14A | 2024-03-13 | 0001193125-24-066805 | CEO total compensation as printed in Inari Medical, Inc.'s own proxy. As printed: 5,083,365. Filing ↗machine: r2 · c31 · span 454508–454517 |
| 43 | LeMaitre Vascular, Inc., Section 10b CEO total | DEF 14A | 2026-04-14 | 0001193125-26-153877 | CEO total compensation as printed in LeMaitre Vascular, Inc.'s own proxy. As printed: 3,780,990. Filing ↗machine: r3 · c18 · span 564038–564047 |
| 44 | Orthopediatrics Corp., Section 10b CEO total | DEF 14A | 2026-04-20 | 0001425450-26-000027 | CEO total compensation as printed in Orthopediatrics Corp.'s own proxy. As printed: 3,331,481. Filing ↗machine: r2 · c36 · span 363407–363416 |
| 45 | Zynex, Inc., Section 10b CEO total | DEF 14A | 2025-03-28 | 0001558370-25-004019 | CEO total compensation as printed in Zynex, Inc.'s own proxy. As printed: 991,810. Filing ↗ |
| 46 | Section 10a, Treace Medical Concepts, Inc. reciprocity | DEF 14A | — | 0001630627-26-000005 | Treace Medical Concepts, Inc.'s most recent proxy was read; its disclosed peer group does not include ANGIODYNAMICS INC. Filing ↗ |
| 47 | Section 10a, Accuray Incorporated reciprocity | DEF 14A | — | 0001140361-26-039918 | Accuray Incorporated names ANGIODYNAMICS INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 48 | Section 10a, Nevro Corp. reciprocity | DEF 14A | — | 0000950170-24-044100 | Nevro Corp. names ANGIODYNAMICS INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 49 | Section 10a, AxoGen, Inc. reciprocity | DEF 14A | — | 0000805928-26-000057 | AxoGen, Inc. names ANGIODYNAMICS INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 50 | Section 10a, Orthofix Medical Inc. reciprocity | DEF 14A | — | 0001193125-26-191716 | Orthofix Medical Inc.'s most recent proxy was read; its disclosed peer group does not include ANGIODYNAMICS INC. Filing ↗ |
| 51 | Section 10a, Inari Medical, Inc. reciprocity | DEF 14A | — | 0001193125-24-066805 | Inari Medical, Inc. names ANGIODYNAMICS INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 52 | Section 10a, Zynex, Inc. reciprocity | DEF 14A | — | 0001558370-25-004019 | Zynex, Inc.'s most recent proxy was read; its disclosed peer group does not include ANGIODYNAMICS INC. Filing ↗ |
| 53 | Section 10a, Glaukos Corporation reciprocity | DEF 14A | — | 0001193125-26-157829 | Glaukos Corporation's most recent proxy was read; its disclosed peer group does not include ANGIODYNAMICS INC. Filing ↗ |
| 54 | Section 10a, Cutera, Inc. reciprocity | DEF 14A | — | 0001628280-24-028528 | Cutera, Inc. names ANGIODYNAMICS INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 55 | Section 10a, Artivion, Inc. reciprocity | DEF 14A | — | 0001999371-26-007510 | Artivion, Inc. names ANGIODYNAMICS INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 56 | Section 10a, AtriCure, Inc. reciprocity | DEF 14A | — | 0001323885-26-000010 | AtriCure, Inc.'s most recent proxy was read; its disclosed peer group does not include ANGIODYNAMICS INC. Filing ↗ |
| 57 | Section 10a, Alphatec Holdings, Inc. reciprocity | DEF 14A | — | 0001193125-26-191867 | Alphatec Holdings, Inc.'s most recent proxy was read; its disclosed peer group does not include ANGIODYNAMICS INC. Filing ↗ |
| 58 | Section 10a, SI-Bone, Inc. reciprocity | DEF 14A | — | 0001459839-26-000049 | SI-Bone, Inc.'s most recent proxy was read; its disclosed peer group does not include ANGIODYNAMICS INC. Filing ↗ |
| 59 | Section 10a, STAAR Surgical Company reciprocity | DEF 14A | — | 0000718937-26-000015 | STAAR Surgical Company's most recent proxy was read; its disclosed peer group does not include ANGIODYNAMICS INC. Filing ↗ |
| 60 | Section 10a, LeMaitre Vascular, Inc. reciprocity | DEF 14A | — | 0001437749-23-010217 | LeMaitre Vascular, Inc. names ANGIODYNAMICS INC in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.
Get the ANGIODYNAMICS INC Executive Compensation Report
$1,500